University of Cambridge > > Science@Darwin > Structure Based Drug Design

Structure Based Drug Design

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Claus Bendtsen.

The first AstraZeneca hosted seminar at our Darwin building on the Cambridge Science Park. The seminar will consist of three presentations:

1) A dual fragment/biochemical screening approach to targeting InhA, a Tuberculosis target by Jon Read from AstraZeneca

2) Structure-based design of potent and selective inhibitors of the metabolic kinase PFKFB3 by Judit Debreczeni from AstraZeneca

3) Crystal Structure of a Class C GPCR – metabotropic glutamate receptor 5 (mGluR5) by Andrew Doré from Heptares

Abstracts & registration @

This talk is part of the Science@Darwin series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2020, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity